Elutia to Report Third Quarter 2024 Financial Results on Thursday, November 14, 2024

Rhea-AI Summary

Elutia (Nasdaq: ELUT), a drug-eluting biomatrix products company, has scheduled its third quarter 2024 financial results release for Thursday, November 14, 2024, after market close. The company will host a conference call and webcast at 4:30 p.m. Eastern Time on the same day. Management will be available for discussion, and investors can access the call through U.S. (877-407-8029) or International (201-689-8029) numbers using Conference ID 13749386.

News Market Reaction – ELUT

-3.94%

-3.94% Session move

In the trading session that priced this news, ELUT declined 3.94%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SILVER SPRING, Md., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a leader in drug-eluting biomatrix products, today announced that it will release its third quarter 2024 financial results after market close on Thursday, November 14, 2024. Members of the Company’s management team will host a conference call and webcast starting at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on the same day.

The conference call can be accessed using the following information.

Webcast: Click here
U.S. Investors: 877-407-8029
International Investors: 201-689-8029
Conference ID: 13749386

Please log in approximately 10 minutes prior to the scheduled start time. A live and archived webcast of the event will be available on the “Investors” section of the Elutia website at http://investors.elutia.com/.

About Elutia
Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.

Investors:
Matt Steinberg
FINN Partners
matt.steinberg@finnpartners.com

FAQ

When will Elutia (ELUT) release Q3 2024 earnings?

Elutia will release its third quarter 2024 financial results after market close on Thursday, November 14, 2024.

What time is Elutia's (ELUT) Q3 2024 earnings call?

Elutia's Q3 2024 earnings conference call is scheduled for 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on November 14, 2024.

How can investors access Elutia's (ELUT) Q3 2024 earnings call?

Investors can access the call via U.S. number (877-407-8029) or International number (201-689-8029) using Conference ID 13749386, or through the webcast available on Elutia's investor relations website.